Private equity firm Mérieux Equity Partners agreed to invest €40m in Swixx Biopharma, a provider of research-based pharmaceutical and healthcare services. "We are delighted to partner with Swixx’s management team, founders and HBM. We look forward to support the company in its next development phase. We have been impressed by how quickly Swixx has established itself as a reputable partner for biopharma clients based upon the highest standards of professionalism, knowledge and service. Mérieux aims to deploy its own expertise and industrial network to support Swixx’s future growth," Benoît Chastaing, MxEP Managing Partner.